OnCore Login

News & Developments

Across the Consortium – May 2017

May 22, 2016:

Across the Consortium is your chance to catch the latest news in Big Ten oncology as it happens each month. We handpick the breaking stories that keep you informed and inspired. This month’s edition highlights major breakthroughs in diagnostics, therapeutics, and discovery.  

Read More

Member Feature: Michigan State University Breslin Cancer Center

May 15, 2017: Jatin Rana, MD Investigator Spotlight Jatin Rana, MD Educational Background: BS from University of Michigan, MS from Wayne State University, and MD from Wayne State University Research Interests: My primary interests both clinically and investigational is in gastrointestinal and breast malignancies. As a young investigator I'm excited to offer treatment opportunities through clinical trials for my patients. I am also involved in developing quality improvement projects to provide the best oncology care for our patients. Fun Facts: I enjoy cooking/grilling. I enjoy hands-on projects including fixing cars and working in the yard. I was born in England. Read More

May is Skin Cancer Detection and Prevention Month

May 7, 2017: The skin protects against heat, sunlight, injury, and infection. Skin also helps control body temperature and stores water and fat. Skin cancer is the most common type of cancer. It usually forms in skin that has been exposed to sunlight, but can occur anywhere on the body. Skin has several layers. According to the National Cancer Institute, skin cancer begins in the epidermis (outer layer), which is made up of squamous cells, basal cells, and melanocytes. You can learn more about skin cancer, including melanoma, from the National Cancer Institute. May is Skin Cancer Detection and Prevention Month.  This month, the members of the Big Ten Cancer Research... Read More

Across the Consortium – April 2017

Apr. 21, 2016: Innovative therapies with hard-hitting impact; that must have been the game plan developed in the last huddle of the Big Ten Cancer Centers!  This month's Across the Consortium is your instant replay of the amazing achievements making headlines across the country, from dynamic new treatments to prototype diagnostics for early detection.  Be inspired as you catch all the action. Read More

Big Ten CRC meetings at ASCO

April 19, 2017: The Big Ten Cancer Research Consortium will host meetings for the Big Ten CRC Foundation, Cancer Center Directors, Steering Committee, and Clinical Trial Working Groups during ASCO 2017. Read More

Member Feature: University of Illinois Cancer Center

April 1, 2017: Investigator Spotlight Lawrence Feldman, MD Educational Background: MD from University of Michigan Research Interests: Dr. Feldman’s research interests lie in finding the optimal treatments to improve the response, survival rates, and quality of life in the treatment of lung and head and neck cancers. He is the UIC Principal Investigator on several studies that test the role of targeted agents in the treatment of lung and head and neck cancer. He is also interested in the application of large databases to answer critical clinical questions in the management of these malignancies. Fun Facts: He is a "gym rat" and loves the game of basketball. His father was a family practice physician and used to make house calls. He and his wife have 2 grown sons and 2... Read More

Across the Consortium – March 2017

March 19, 2017: Each month, the Big Ten Cancer Research Consortium highlights advances in research and treatment led by our member institutions. Get up to date on the latest discoveries and breakthroughs from Across the Consortium!  Read More

March is Colorectal Cancer Awareness Month

March 11, 2017: March is the time to take stock of the number two ranking cause of cancer deaths in the United States: colorectal cancer (cancer of the colon or rectum). Since this time last year, it is estimated that 140,000 Americans were diagnosed with colorectal cancer, and more than 50,000 people died from it. During Colorectal Cancer Awareness Month, researchers, clinicians, survivors, and patients unite with the common purpose of discovering hope for those facing this cancer.  Read More

New study combines CDK and androgen receptor inhibitors in triple negative breast cancer

March 3, 2017: Triple negative breast cancer (TNBC) represents a relatively small proportion — 15 percent — of all breast cancers. Yet a great deal of attention has been given to TNBC in recent years. While targeted therapies have been developed for breast cancers expressing estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2, advances in TNBC have been hampered by a lack of identified targets for the disease. As a result, the only approved treatment for TNBC remains chemotherapy. Recent discoveries, however, have identified several molecular subtypes of TNBC, and researchers are now developing clinical trials to explore potential ways to treat these subtypes. A new Big Ten Cancer Research Consortium study, led by Ruth O’Regan, MD (pictured), of the University of Wisconsin... Read More

Member Feature: Rutgers Cancer Institute of New Jersey

March 1, 2017: Investigator Spotlight Mark Stein, MD Educational Background: BS, Yale; MD, New York Medical College; Internal Medicine, Albert Einstein; Fellowship in Oncology Hematology, Mount Sinai School of Medicine Rutgers Cancer Institute of New Jersey. 1/13/17 Photo by John O'Boyle Research Interests: I am interested in developing novel therapies for the treatment of genitourinary malignancies. The potential benefit of immunotherapy for the treatment of prostate cancer is still poorly understood. Through collaboration’s with my colleagues at Rutgers, pharmaceutical companies (some of which are even located in New Jersey) and other members of the Big Ten, it is my hope that we will be able to utilize immunotherapy earlier in the course of treatment of prostate cancer and... Read More

University of Illinois

University of Illinois

Indiana University

Indiana University

University of Iowa

University of Iowa

University of Michigan

University of Michigan

Michigan State

Michigan State

University of Minnesota

University of Minnesota

University of Nebraska

University of Nebraska

Northwestern University

Northwestern University

Penn State University

Penn State University

Purdue University

Purdue University

Rutgers State University

Rutgers State University

University of Wisconsin

University of Wisconsin

© 2017 All rights reserved.

Big Ten Cancer Research Consortium
500 N. Meridian Street, Suite 100, Indianapolis, IN 46204

email: info@bigtencrc.org    phone: 317–921–2050